Your browser does not support scripts, this page will not display properly!
ISMP (US)
Contact Us
Feedback
Search:
ISMP Canada News
Jan 12, 2022:
Health Canada: Xeljanz (tofacitinib) risk of serious heart issues and cancer
Health Canada: Xeljanz (tofacitinib) risk of serious heart issues and cancer
Copyright © 2000-2016 Institute for Safe Medication Practices Canada (ISMP Canada). All Rights Reserved.